Our model posits that asparaginase-resistant leukemias rely on proteasomal degradation of proteins, a catabolic source of amino acids,90 to maintain asparagine levels above a critical threshold during treatment with asparaginase, an adaptive pathway blocked by the inhibition of SOD2-dependent protein degradation. The gene discussed is SOD2; the disease is leukemia.